Orbital Manufacturing

The microgravity advantage

Why Microgravity Changes Manufacturing

Gravity is a contaminant. Remove it and the materials change.

Four physical effects vanish in microgravity that dominate manufacturing on Earth. Convection — buoyancy-driven fluid flow that mixes temperature and concentration gradients, causing defects in crystals and alloys. Sedimentation — heavier components settling to the bottom of a mixture, preventing uniform distribution. Hydrostatic pressure — the weight of a liquid column that compresses structures during solidification. Container-wall effects — surface tension dominates in microgravity, so liquids form free-floating spheres rather than conforming to container walls, eliminating wall-nucleated defects.

The result is that certain classes of materials form with dramatically fewer defects in orbit than on Earth. Crystals grow larger and more uniform. Fiber optics draw with fewer microcrystallites. Alloys solidify with denser, more homogeneous microstructures. Protein crystals used in drug development form with higher resolution, revealing molecular structures that ground-grown crystals obscure. These are not theoretical predictions — they have been demonstrated repeatedly on the ISS over 25 years of microgravity research.

The vacuum of space adds a second advantage. The hard vacuum outside the spacecraft (10&sup-10; to 10&sup-12; torr) enables ultra-pure thin-film deposition, contamination-free processing, and vapor-phase manufacturing that would require expensive vacuum chambers on Earth. And unfiltered solar flux can be concentrated for high-temperature processing or used as an energy source for photochemical reactions.

ISS: the proving ground

Twenty-Five Years of Microgravity Research on the International Space Station

Everything in orbital manufacturing traces back to ISS experiments.

The ISS has hosted over 3,800 experiments across its operational life, including hundreds in materials science, fluid physics, crystal growth, and biological manufacturing. Key milestones relevant to the commercial manufacturing pipeline:

ZBLAN fiber optics. Fluoride glass fiber (ZrF&sub4;-BaF&sub2;-LaF&sub3;-AlF&sub3;-NaF) that at its theoretical best has 10–100× lower signal loss than silica fiber. Earth-made ZBLAN suffers from gravity-driven convection that causes microcrystallite defects during cooling. Multiple organizations have drawn ZBLAN on the ISS — Made In Space (now Redwire), FOMS, Physical Optics Corporation, and Flawless Photonics. In early 2024, Flawless Photonics drew more than seven miles of ZBLAN in a single ISS campaign, with individual draws exceeding 700 meters — the first demonstration of commercial-length fiber production in space.

Protein crystal growth. Hundreds of protein crystallization experiments have flown on the ISS across NASA, ESA, JAXA, and commercial payloads. Microgravity-grown crystals are consistently larger and more ordered than ground controls, yielding higher-resolution X-ray diffraction data. This matters for pharmaceutical structure-based drug design — a sharper crystal structure means better understanding of how a drug molecule binds to its target. Merck, Eli Lilly, and other pharma companies have flown experiments.

Bioprinting. Redwire’s BioFabrication Facility (BFF) on the ISS has printed living human heart tissue samples and a knee meniscus in microgravity — structures that collapse under their own weight during ground-based bioprinting. As of 2026, BFF is a fully operational orbital bioprinting laboratory.

Semiconductor and materials research. Redwire’s MSTIC (Microgravity Semiconductor and Technology Innovation Center) platform launched to the ISS in 2024 to demonstrate autonomous semiconductor crystal growth. Colloids experiments (COLIS platform) continue as of April 2026. Containerless electrostatic levitation experiments on Tiangong have produced 565 experimental records across metallic alloys and ceramics.

3D printing. Redwire operates more than 10 manufacturing installations on the ISS, including additive manufacturing facilities. ESA successfully 3D-printed metal parts on the ISS in 2025 — the first metal additive manufacturing in orbit.

The ISS is scheduled for deorbit in 2031. The question of where microgravity manufacturing research continues after ISS retirement is answered by two paths: commercial stations (see Crewed Stations) and autonomous free-flying platforms like Varda and Starfall.

Products and verticals

What Can Be Made in Orbit: Product Categories

Only products whose value per kilogram justifies the round trip.

The economic filter is severe: only products whose value per kilogram exceeds the cost of launch, orbital processing time, and reentry recovery justify the round trip. At current launch prices ($2,700–$7,000/kg up, plus recovery), that limits the market to pharmaceuticals, specialty optics, semiconductor substrates, and research samples. If Starship reduces launch cost by an order of magnitude, the addressable product set widens substantially.

Manufacturing platforms

Orbital Manufacturing Platforms: From ISS Racks to Autonomous Capsules

The shift from crewed-station experiments to autonomous free-flying factories.

SpaceX Starfall. Demonstrated June 23, 2026. A disk-shaped autonomous reentry capsule — 0.75 m tall, 3.1 m diameter, 2,100 kg unladen — with a payload bay 2.5 m long, 1.5 m wide, and 0.5 m tall holding up to 1,000 kg. The top plate is aluminum with thermal protection; the bottom half is a detachable carbon-fiber heat shield. Starfall carries integrated Starlink terminals that maintain telemetry through the reentry plasma blackout. The capsule launches on Falcon 9 (one capsule) or Starship (multiple capsules per flight), orbits for days to weeks while its payload processes in microgravity, then separates and reenters autonomously at Mach 25+, deploying parachutes for ocean splashdown. The demo carried brewing yeasts; the first commercial contract was announced August 6, 2026 — Redwire’s SpaceMD subsidiary booked 32 PIL-BOX drug-crystallization units for a 2028 Starfall mission, capable of processing over 100 distinct drug compound experiments in a single return trip. Starfall is a platform, not a product — customers supply the payload hardware; SpaceX supplies launch, orbital loiter, and return as a service.

Varda Space Industries. Three-part vehicle: a Rocket Lab-built satellite bus (for power, attitude control, and communications), a reentry capsule (heat shield, parachute, structural shell), and inside the capsule, the autonomous pharmaceutical reactor. The reactor is where the manufacturing happens. It contains fluid-handling hardware that moves solutions between sealed containers — dissolving an API (active pharmaceutical ingredient) in a solvent, then mixing it with an antisolvent to trigger controlled crystallization. Temperature control (heating and cooling cycles), in-situ sensors (video microscopy, Raman spectroscopy, infrared), and automated valving let the reactor execute a crystallization protocol autonomously over days to weeks in microgravity. The W-1 mission produced Form III ritonavir — a specific crystalline polymorph of the HIV antiviral drug that is difficult to create consistently on Earth. Microgravity eliminates convection-driven mixing during crystal growth, producing more uniform crystal size distributions and enabling novel polymorphs with better stability, purity, and bioavailability. The capsule reenters at Mach 25 behind a PICA (Phenolic Impregnated Carbon Ablator) heat shield, landing under parachute. Six missions flown, three capsules recovered. $145M raised, $500M valuation. El Segundo, California.

Space Forge (UK). ForgeStar 1, launched July 2025, is a free-flying returnable satellite carrying semiconductor crystal growth hardware. The concept: melt a semiconductor feedstock in a micro-furnace, allow it to resolidify in microgravity (no convection, no container-wall nucleation), then return the resulting crystal to Earth inside the reentry vehicle. Microgravity and the hard vacuum of space together eliminate the two largest sources of defects in semiconductor crystal growth. Partnership with Intuitive Machines for recovery. $30M raised.

Redwire Space ISS facilities. Redwire operates 10+ manufacturing installations aboard the ISS. The BioFabrication Facility (BFF) is a 3D bioprinter that extrudes cell-laden bioinks layer by layer; in microgravity the printed structure holds its shape instead of collapsing, enabling tissue geometries (meniscus, cardiac patches) that slump on Earth. The ZBLAN draw system heats a fluoride glass preform and draws it into fiber through a nozzle, the same process used terrestrially but without convection-driven microcrystallite formation during cooling. The MSTIC semiconductor platform grows crystals from melt in sealed ampoules under automated thermal control. The COLIS colloids instrument studies particle self-assembly. Each facility is a self-contained experiment rack roughly the size of a mini-fridge, designed for the ISS’s standardized payload interfaces.

ISS National Lab / Commercial stations. The ISS remains the primary crewed microgravity laboratory through its planned 2031 deorbit. Post-ISS, commercial stations from Axiom Space ($350M raised, February 2026), Vast, and Orbital Reef (Blue Origin / Sierra Space) will host manufacturing payloads. The transition is from ISS-scale shared laboratory to a market with multiple stations, autonomous capsules (Varda, Starfall), and free-flying platforms (Space Forge) operating in parallel.

Operators and companies

Orbital Manufacturing Companies and Programs

The companies building the factories.

China

Chinese Microgravity Research and In-Space Manufacturing

Tiangong is a materials science laboratory.

China’s Tiangong space station, completed in 2022, supports large-scale microgravity research across materials science, fluid physics, life sciences, and combustion science. The Tianzhou-9 cargo mission (2025) delivered 776 kg of experimental payloads covering 23 scientific experiments. Tiangong’s containerless electrostatic levitation platform has produced 565 experimental records — 420 on-orbit and 145 ground-matched — across metallic alloys, ceramics, and other materials, enabling direct comparison between gravitational and microgravity environments.

Tiangong has demonstrated artificial photosynthesis in space — producing oxygen and rocket fuel precursors from CO&sub2; using engineered catalysts — with precise control of gas and liquid flows in microgravity, a capability directly relevant to in-space manufacturing process control. The Shijian-25 satellite (January 2025) tested in-orbit refueling technologies, creating a potential future ecosystem where Tiangong produces fuel components that servicing satellites distribute.

Chinese commercial space manufacturing is earlier-stage than the US but accelerating. Key programs are covered on the Orbital Compute page (Three-Body constellation, Comospace, Orbital Chenguang), as China’s orbital manufacturing and orbital compute programs overlap substantially — the same satellites that process AI workloads can process materials data and control manufacturing experiments. CASC’s 15th Five-Year Plan includes space-based manufacturing as a strategic priority alongside computing infrastructure.

The economics

Orbital Manufacturing Economics: What Closes and What Does Not

The round-trip cost sets the floor. Only high-value products clear it.

The in-space manufacturing market was valued at $1.5 billion in 2026 and is projected to reach $6 billion by 2034 at a 17% CAGR. But the economics are constrained by a simple filter: the value per kilogram of the product must exceed the cost per kilogram of the round trip (launch up + orbital processing time + reentry and recovery).

At current Falcon 9 pricing, a round trip costs roughly $15,000–$30,000 per kilogram including launch, orbital operations, and capsule recovery. That eliminates anything that can be made cheaper on Earth. What survives the filter: pharmaceutical compounds whose microgravity crystal form has superior bioavailability (a reformulated drug can be worth billions in patent extension); ZBLAN fiber optics worth $150,000–$1 million per kilometer; semiconductor substrates whose defect-free crystal structure commands premium pricing; and bioprinted tissue samples whose research value is not measured per kilogram.

The Starfall architecture changes the economics in one specific way: it decouples orbital manufacturing from crewed stations. An autonomous capsule that launches on a Falcon 9, orbits for days or weeks processing materials in microgravity, and returns autonomously eliminates the overhead of crew time, life support, and station logistics. If Starship can carry multiple Starfall capsules per launch, the per-capsule cost drops further. The transition is from bespoke ISS experiments to a repeatable, scalable, autonomous manufacturing loop — and that is what converts orbital manufacturing from research into industry.